DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline systemic lupus erythematosus therapies in various stages of clinical ...
Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback